Developer docs
API playgroundTry for free, no card

Search company profiles

Asia Healthcare Holdings(AHH)

Full company profile

uuid0000ppe

Namestring
Asia Healthcare Holdings(AHH)
Legal namestring
Asia Healthcare Holdings
Websiteurl
ahholdings.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Asia Healthcare Holdings (AHH) is a single-specialty healthcare operating and investment platform founded in April 2016 by TPG Growth, focused exclusively on building and acquiring branded specialty clinical businesses in India. AHH currently operates three core verticals: Motherhood Hospitals (women and child care, including obstetrics, gynecology, and pediatric services), Nova IVF Fertility (assisted reproduction across 98+ centers), and the Asian Institute of Nephrology and Urology (AINU, a urology and nephrology chain of 7 hospitals with 500+ beds acquired in September 2023 for approximately Rs 600 crore). The platform also operates internal pathology and diagnostics businesses embedded within Motherhood and Nova IVF, with Motherhood diagnostics alone generating Rs 35 crore in revenue. Collectively, AHH runs 150+ hospitals and clinics across 80+ Indian cities, employs 6,100 staff including 2,000 specialist doctors, and is targeting further expansion into Tier-2 and Tier-3 markets as well as adjacent specialties such as gastroenterology.

AHH's business model is patient-pay and insurance-reimbursed specialty clinical care delivered through owned and operated facilities under unified specialty brands. Revenue is generated per clinical episode — deliveries, IVF cycles, urological procedures, dialysis sessions, and ancillary diagnostics — with cross-vertical referral economics, shared back-office, centralized procurement, and a common technology stack creating operating leverage unavailable to standalone operators. The platform has attracted growth capital from GIC, which acquired a 40% stake for approximately $170 million in February 2022, and is currently preparing for a potential public listing within 12-18 months while continuing inorganic expansion (most recently the CRAFT Hospitals acquisition in March 2026 for approximately $40 million).

AHH's stated capital plan calls for $400-500 million of deployment over five years and $150 million over the next two years, financed through a combination of follow-on capital from existing sponsors, operating cash flow, and IPO proceeds. Governance has been upgraded in 2026 with the appointment of Venkatesh Tarakkad as CFO, Ritesh Pandey in a newly created CBO role, and three independent directors. The platform is led by Executive Chairman Vishal Bali and supported by brand-level CEOs across Motherhood, Nova IVF, and AINU.

Short descriptiontext

Asia Healthcare Holdings is a TPG Growth-founded single-specialty healthcare platform operating Motherhood Hospitals, Nova IVF Fertility, and AINU across 150+ facilities and 80+ Indian cities, serving patients in women/maternal care, fertility, and urology/nephrology.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersBengaluru, India
HQ citystring
Bengaluru
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
single-specialty healthcare, fertility treatment services, women and child healthcare, urology and nephrology care, healthcare investment platform
Industry2 codes
1Hospital-at-Home / Acute Care at Home Programs
CodeHLAFAEAHPrimaryYes
2Multi-Location & Enterprise Practice Operations
CodeHLACADAGPrimaryNo
NAICS code3 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • Specialty (except Psychiatric and Substance Abuse) Hospitals6223
  • Offices of Physicians, Mental Health Specialists621112
SIC code2 codes
  • Services-Hospitals8060
  • Services-Misc Health & Allied Services, Nec8090
Product category
Single-specialty healthcare services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Hospital & clinical service revenue
TypeManaged Services
Description

Recurring revenue generated through operating single-specialty hospital chains (Motherhood Hospitals, Nova IVF Fertility, AINU) that bill patients for in-patient, out-patient, surgical, fertility, and diagnostic services across 80+ Indian cities.

ahholdings.com
2In-house pathology & diagnostic revenue
TypeManaged Services
Description

Cross-vertical internal pathology services delivered to AHH's own hospitals, currently generating about 400 million rupees (~$4.20M) of pathology work, with planned expansion as a standalone vertical.

in.investing.com
3Healthcare investment platform returns
TypeLicensing Royalties
Description

Capital appreciation and exits from portfolio investments; AHH has invested approximately $200M to date across healthcare enterprises and exited American Oncology Institute (CTSI) to Varian Medical Systems in 2019.

ahholdings.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Service fees vary by hospital, treatment, and city; no published price list.
ModelOther
Notes

Pricing is quote-based and not publicly disclosed. Patient-facing pricing differs across Motherhood Hospitals, Nova IVF Fertility, and AINU and is not standardized or published on the corporate website.

ahholdings.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 4 records shown
1Motherhood Hospitals
Description

India's fastest-growing single-specialty women & children's hospital network (23 hospitals + 2 clinics, 1000+ gynaecologists/paediatricians/neonatologists).

ahholdings.com
+3 more records
Core offering1 text field

Asia Healthcare Holdings (AHH) is a single-specialty healthcare operating and investment platform that acquires and scales hospital and clinic chains in India across three verticals: women and child care (Motherhood Hospitals), fertility and IVF (Nova IVF Fertility), and urology and nephrology (Asian Institute of Nephrology and Urology / AINU). The platform combines institutional capital (TPG Growth and GIC) with operating expertise to grow more than 150 hospitals and clinics across 80+ Indian cities, employing 6,100 staff and 2,000 doctors. AHH also runs in-house pathology work worth roughly 400 million rupees and is scoping gastroenterology as a future vertical.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Asia Healthcare Holdings (AHH) is a single-specialty healthcare operating and investment platform - not a unified software product but a portfolio of independently operated specialty healthcare enterprises. AHH was incubated by TPG Growth in April 2016 and is now backed by TPG Growth and Singapore's sovereign wealth fund GIC. Its current portfolio comprises three core single-specialty enterprises: Motherhood Hospitals (women and child care hospital network), Nova IVF Fertility (fertility treatment chain), and the Asian Institute of Nephrology and Urology / AINU (urology and nephrology chain). AHH previously also owned American Oncology Institute (CTSI), which was exited to Varian Medical Systems in 2019. The platform combines capital, operating expertise, and clinical governance to scale these specialty brands - rather than offering a single unified technology product - and is currently exploring additional verticals such as gastroenterology and pathology diagnostics ahead of a potential IPO.

Product and service4 records
1Motherhood Hospitals
CategorySingle-specialty hospital chain (Women and Child Care)
Description

India's fastest-growing single-specialty women and children's hospital network offering obstetrics, gynaecology, neonatology, pediatric intensive care, and fertility & IVF services. Operates 23 hospitals + 2 clinics with 1,000+ leading gynaecologists, paediatricians and neonatologists, and the largest network of NICUs in India. Targets expectant mothers, neonates, and pediatric patients.

2Nova IVF Fertility
CategorySingle-specialty fertility clinic chain
Description

Among the largest fertility treatment service providers in India, offering advanced Assisted Reproductive Technology (ART) on par with global standards with standardised and ethical infertility treatment. Operates 98+ fertility centres across 63 cities in India with 120+ doctors and 150+ embryologists; targets couples and individuals seeking fertility treatment, and addresses the need for organized institutional fertility providers.

3Asian Institute of Nephrology and Urology (AINU)
CategorySingle-specialty urology and nephrology hospital chain
Description

India's largest single-specialty hospital network for urology and nephrology care, with pioneering work in robotic urology surgery. Operates 7 hospitals across Hyderabad, Visakhapatnam, Siliguri and Chennai with 500+ beds, 400,000+ patients treated, 50,000+ procedures, 1,000+ robotic urology surgeries, 200,000+ dialysis procedures and 300 kidney transplants. Founded in 2013 by Dr. C. Mallikarjuna and Dr. P. C. Reddy.

4In-house Pathology and Diagnostics Services
CategoryPathology and diagnostic services
Description

Cross-vertical internal pathology services delivered to AHH's own hospitals across the Motherhood, Nova IVF, and AINU networks, generating about 400 million rupees of internal work, with planned expansion as a standalone diagnostics vertical.

Scale indicator17 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-01
Description

Nova IVF Fertility acquired a majority stake in Kerala-based CRAFT Hospitals for approximately $40 million (₹368 crore). Craft Fertility has over 55,000 babies born and 30+ years of operating history. The deal was facilitated by investment bank Advay Capital. Nova IVF plans to open 10 new centres in Kerala over 3-5 years.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-03-01
Description

Investment bank Advay Capital advised CRAFT Fertility and its promoter on the sale of a majority stake to Nova IVF Fertility for $40 million (₹368 crore). One-off M&A advisory mandate; not an ongoing alliance.

3Wings (Ahmedabad IVF company)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-06-01
Description

Nova IVF Fertility (AHH platform) acquired Wings, an Ahmedabad-based IVF company, to expand Nova IVF's presence in Gujarat.

ahholdings.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-01
Description

Motherhood Hospitals (AHH platform) made a strategic investment in Chaitanya Hospital, the leading provider of women and children healthcare services in the Chandigarh Tricity (Chandigarh, Mohali, Panchkula, Zirakpur) for over two decades. The combined entity covers Obstetrics & Gynaecology, Neonatology, Pediatric Intensive Care, Fertility & IVF.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-09-01
Description

Motherhood Hospitals (AHH platform) acquired Bengaluru-based Femiint Hospitals as part of its expansion into Karnataka and Bengaluru.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-05-01
Description

Nova IVF Fertility (AHH platform) made a strategic investment in Southend Fertility & IVF, a leading IVF player in Delhi NCR, to expand its presence in the NCR region. The combined entity operates comprehensive fertility centres backed by advanced technology and experienced fertility experts.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-05-01
Description

AHH divested its American Oncology / Cancer Treatment Services International (CTSI) chain — which had grown to 11 hospitals across South Asia — to Varian Medical Systems in May 2019. No ongoing operating partnership; the relationship is historical.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

One of India's largest multi-specialty hospital chains; overlaps with AHH on women & child, tertiary, and specialty care infrastructure across India. Operates a much broader portfolio of services but competes for the same patient base and clinical talent that AHH's single-specialty brands target.

TypeBroad incumbent
Description

Large Indian hospital chain (and former employer of AHH's Executive Chairman Vishal Bali and Motherhood CEO Vijayrathna Venkatraman). Competes for the same tertiary and specialty patient demand and draws on overlapping clinician pools, making it a direct comparator for hospital-network scale and quality accreditation.

TypeBroad incumbent
Description

India's flagship multi-specialty hospital brand; AHH's CTO previously served as CIO of Apollo. Comparable on hospital-chain operations, technology-led care delivery, and clinical quality benchmarks, and an obvious comparison set for the planned IPO.

TypeBroad incumbent
Description

Listed North-India multi-specialty hospital network with strong tertiary and quaternary care. Comparable in terms of urban, single-specialty-adjacent service lines (mother & child, urology, IVF) and a relevant IPO/liquidity benchmark for AHH's public-market trajectory.

TypeDirect peer
Description

India's leading single-specialty women, maternity and child-care hospital chain with a comparable NICU- and gynaecology-led model. Direct competitor to Motherhood Hospitals across metros and Tier-1 cities and the closest pure-play comparable for that AHH vertical.

TypeDirect peer
Description

Single-specialty paediatric, women and child hospital chain listed in India. Direct competitor to Motherhood in the same NICU-led, paediatric subspecialty category and a key public-market reference for AHH's women & child vertical.

TypeDirect peer
Description

Among India's largest fertility/IVF chains by centre count, competing head-to-head with Nova IVF in tier-1 and tier-2 cities. Closest pure-play direct comparable on the fertility vertical that anchors AHH's growth thesis.

TypeDirect peer
Description

Pan-India fertility chain with ART and embryology services that overlap directly with Nova IVF. Comparable on clinical protocol standardisation, embryologist scale, and tier-2/3 city expansion strategy.

TypeEmerging player
Description

Technology-driven, distributed cancer-care platform in India where AHH's CTO previously served as CIO. Relevant because it operates a tech-enabled specialty model, intersects with AHH's former oncology vertical, and is a candidate counterparty for any future oncology re-entry or partnership.

TypeBroad incumbent
Description

Multi-specialty hospital chain in India with strong presence in urology, nephrology and dialysis — directly adjacent to AHH's AINU vertical. Comparable for hospital-network scaling, dialysis-program throughput, and transplant capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Asia Healthcare Holdings(AHH)

Single-specialty healthcare servicesahholdings.com

Asia Healthcare Holdings is a TPG Growth-founded single-specialty healthcare platform operating Motherhood Hospitals, Nova IVF Fertility, and AINU across 150+ facilities and 80+ Indian cities, serving patients in women/maternal care, fertility, and urology/nephrology.

What Asia Healthcare Holdings(AHH) does

Asia Healthcare Holdings (AHH) is a single-specialty healthcare operating and investment platform founded in April 2016 by TPG Growth, focused exclusively on building and acquiring branded specialty clinical businesses in India. AHH currently operates three core verticals: Motherhood Hospitals (women and child care, including obstetrics, gynecology, and pediatric services), Nova IVF Fertility (assisted reproduction across 98+ centers), and the Asian Institute of Nephrology and Urology (AINU, a urology and nephrology chain of 7 hospitals with 500+ beds acquired in September 2023 for approximately Rs 600 crore). The platform also operates internal pathology and diagnostics businesses embedded within Motherhood and Nova IVF, with Motherhood diagnostics alone generating Rs 35 crore in revenue. Collectively, AHH runs 150+ hospitals and clinics across 80+ Indian cities, employs 6,100 staff including 2,000 specialist doctors, and is targeting further expansion into Tier-2 and Tier-3 markets as well as adjacent specialties such as gastroenterology.

AHH's business model is patient-pay and insurance-reimbursed specialty clinical care delivered through owned and operated facilities under unified specialty brands. Revenue is generated per clinical episode — deliveries, IVF cycles, urological procedures, dialysis sessions, and ancillary diagnostics — with cross-vertical referral economics, shared back-office, centralized procurement, and a common technology stack creating operating leverage unavailable to standalone operators. The platform has attracted growth capital from GIC, which acquired a 40% stake for approximately $170 million in February 2022, and is currently preparing for a potential public listing within 12-18 months while continuing inorganic expansion (most recently the CRAFT Hospitals acquisition in March 2026 for approximately $40 million).

AHH's stated capital plan calls for $400-500 million of deployment over five years and $150 million over the next two years, financed through a combination of follow-on capital from existing sponsors, operating cash flow, and IPO proceeds. Governance has been upgraded in 2026 with the appointment of Venkatesh Tarakkad as CFO, Ritesh Pandey in a newly created CBO role, and three independent directors. The platform is led by Executive Chairman Vishal Bali and supported by brand-level CEOs across Motherhood, Nova IVF, and AINU.

Asia Healthcare Holdings(AHH) firmographics

Firmographics
Name
Asia Healthcare Holdings(AHH)
Legal name
Asia Healthcare Holdings
Website
https://ahholdings.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Asia Healthcare Holdings is a TPG Growth-founded single-specialty healthcare platform operating Motherhood Hospitals, Nova IVF Fertility, and AINU across 150+ facilities and 80+ Indian cities, serving patients in women/maternal care, fertility, and urology/nephrology.
Ownership category
akta.pro rank

Asia Healthcare Holdings(AHH) industry classification

Industry
Product category
Single-specialty healthcare services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Offices of Physicians, Mental Health Specialists (621112)
SIC
Services-Hospitals (8060), Services-Misc Health & Allied Services, Nec (8090)
akta.pro primary industry
Hospital-at-Home / Acute Care at Home Programs (HLAFAEAH)
akta.pro secondary industry
Multi-Location & Enterprise Practice Operations (HLACADAG)

Keywords

  • Single-specialty healthcare
  • Fertility treatment services
  • Women and child healthcare
  • Urology and nephrology care
  • Healthcare investment platform

Where Asia Healthcare Holdings(AHH) is headquartered

Location

Headquarters

HQ city
Bengaluru
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Asia Healthcare Holdings(AHH) business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Hospital & clinical service revenue: Recurring revenue generated through operating single-specialty hospital chains (Motherhood Hospitals, Nova IVF Fertility, AINU) that bill patients for in-patient, out-patient, surgical, fertility, and diagnostic services across 80+ Indian cities.
  2. In-house pathology & diagnostic revenue: Cross-vertical internal pathology services delivered to AHH's own hospitals, currently generating about 400 million rupees (~$4.20M) of pathology work, with planned expansion as a standalone vertical.
  3. Healthcare investment platform returns: Capital appreciation and exits from portfolio investments; AHH has invested approximately $200M to date across healthcare enterprises and exited American Oncology Institute (CTSI) to Varian Medical Systems in 2019.

Pricing tiers

ModelBillingPrice
Other—Service fees vary by hospital, treatment, and city; no published price list.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Asia Healthcare Holdings(AHH) product offering

Product offering

Core offering

Asia Healthcare Holdings (AHH) is a single-specialty healthcare operating and investment platform that acquires and scales hospital and clinic chains in India across three verticals: women and child care (Motherhood Hospitals), fertility and IVF (Nova IVF Fertility), and urology and nephrology (Asian Institute of Nephrology and Urology / AINU). The platform combines institutional capital (TPG Growth and GIC) with operating expertise to grow more than 150 hospitals and clinics across 80+ Indian cities, employing 6,100 staff and 2,000 doctors. AHH also runs in-house pathology work worth roughly 400 million rupees and is scoping gastroenterology as a future vertical.

Product overview

Asia Healthcare Holdings (AHH) is a single-specialty healthcare operating and investment platform - not a unified software product but a portfolio of independently operated specialty healthcare enterprises. AHH was incubated by TPG Growth in April 2016 and is now backed by TPG Growth and Singapore's sovereign wealth fund GIC. Its current portfolio comprises three core single-specialty enterprises: Motherhood Hospitals (women and child care hospital network), Nova IVF Fertility (fertility treatment chain), and the Asian Institute of Nephrology and Urology / AINU (urology and nephrology chain). AHH previously also owned American Oncology Institute (CTSI), which was exited to Varian Medical Systems in 2019. The platform combines capital, operating expertise, and clinical governance to scale these specialty brands - rather than offering a single unified technology product - and is currently exploring additional verticals such as gastroenterology and pathology diagnostics ahead of a potential IPO.

Differentiator

Problem solved

Functional benefit

Brands

  • Motherhood Hospitals: India's fastest-growing single-specialty women & children's hospital network (23 hospitals + 2 clinics, 1000+ gynaecologists/paediatricians/neonatologists).
  • Nova IVF Fertility (NIF)
  • Asian Institute of Nephrology and Urology (AINU)
  • American Oncology Institute

Products and services

  • Motherhood Hospitals India's fastest-growing single-specialty women and children's hospital network offering obstetrics, gynaecology, neonatology, pediatric intensive care, and fertility & IVF services. Operates 23 hospitals + 2 clinics with 1,000+ leading gynaecologists, paediatricians and neonatologists, and the largest network of NICUs in India. Targets expectant mothers, neonates, and pediatric patients.
  • Nova IVF Fertility Among the largest fertility treatment service providers in India, offering advanced Assisted Reproductive Technology (ART) on par with global standards with standardised and ethical infertility treatment. Operates 98+ fertility centres across 63 cities in India with 120+ doctors and 150+ embryologists; targets couples and individuals seeking fertility treatment, and addresses the need for organized institutional fertility providers.
  • Asian Institute of Nephrology and Urology (AINU) India's largest single-specialty hospital network for urology and nephrology care, with pioneering work in robotic urology surgery. Operates 7 hospitals across Hyderabad, Visakhapatnam, Siliguri and Chennai with 500+ beds, 400,000+ patients treated, 50,000+ procedures, 1,000+ robotic urology surgeries, 200,000+ dialysis procedures and 300 kidney transplants. Founded in 2013 by Dr. C. Mallikarjuna and Dr. P. C. Reddy.
  • In-house Pathology and Diagnostics Services Cross-vertical internal pathology services delivered to AHH's own hospitals across the Motherhood, Nova IVF, and AINU networks, generating about 400 million rupees of internal work, with planned expansion as a standalone diagnostics vertical.

Companies that use Asia Healthcare Holdings(AHH)

Customer profile

Segments5 records

Ideal customer profiles2 records

Asia Healthcare Holdings(AHH) technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Asia Healthcare Holdings(AHH) partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • CRAFT Hospitals (Craft Fertility, Kerala)coreStrategic or Co-development Partner · 1 March 2026Nova IVF Fertility acquired a majority stake in Kerala-based CRAFT Hospitals for approximately $40 million (₹368 crore). Craft Fertility has over 55,000 babies born and 30+ years of operating history. The deal was facilitated by investment bank Advay Capital. Nova IVF plans to open 10 new centres in Kerala over 3-5 years.
  • Advay CapitalminorImplementation/ SI/ Consulting Partner · 1 March 2026Investment bank Advay Capital advised CRAFT Fertility and its promoter on the sale of a majority stake to Nova IVF Fertility for $40 million (₹368 crore). One-off M&A advisory mandate; not an ongoing alliance.
  • Wings (Ahmedabad IVF company)minorStrategic or Co-development Partner · 1 June 2023Nova IVF Fertility (AHH platform) acquired Wings, an Ahmedabad-based IVF company, to expand Nova IVF's presence in Gujarat.
  • Chaitanya HospitalcoreStrategic or Co-development Partner · 1 September 2022Motherhood Hospitals (AHH platform) made a strategic investment in Chaitanya Hospital, the leading provider of women and children healthcare services in the Chandigarh Tricity (Chandigarh, Mohali, Panchkula, Zirakpur) for over two decades. The combined entity covers Obstetrics & Gynaecology, Neonatology, Pediatric Intensive Care, Fertility & IVF.
  • Femiint Hospitals (Bengaluru)minorStrategic or Co-development Partner · 1 September 2022Motherhood Hospitals (AHH platform) acquired Bengaluru-based Femiint Hospitals as part of its expansion into Karnataka and Bengaluru.
  • Southend Fertility & IVFcoreStrategic or Co-development Partner · 1 May 2019Nova IVF Fertility (AHH platform) made a strategic investment in Southend Fertility & IVF, a leading IVF player in Delhi NCR, to expand its presence in the NCR region. The combined entity operates comprehensive fertility centres backed by advanced technology and experienced fertility experts.
  • Varian Medical SystemsminorStrategic or Co-development Partner · 1 May 2019AHH divested its American Oncology / Cancer Treatment Services International (CTSI) chain — which had grown to 11 hospitals across South Asia — to Varian Medical Systems in May 2019. No ongoing operating partnership; the relationship is historical.

Scale indicators17 records

Recent moves8 records

Expansion highlights6 records

Asia Healthcare Holdings(AHH) competitors and assessment

Company assessment

Broad incumbents

  • Manipal Hospitals: One of India's largest multi-specialty hospital chains; overlaps with AHH on women & child, tertiary, and specialty care infrastructure across India. Operates a much broader portfolio of services but competes for the same patient base and clinical talent that AHH's single-specialty brands target.
  • Fortis Healthcare: Large Indian hospital chain (and former employer of AHH's Executive Chairman Vishal Bali and Motherhood CEO Vijayrathna Venkatraman). Competes for the same tertiary and specialty patient demand and draws on overlapping clinician pools, making it a direct comparator for hospital-network scale and quality accreditation.
  • Apollo Hospitals: India's flagship multi-specialty hospital brand; AHH's CTO previously served as CIO of Apollo. Comparable on hospital-chain operations, technology-led care delivery, and clinical quality benchmarks, and an obvious comparison set for the planned IPO.
  • Max Healthcare: Listed North-India multi-specialty hospital network with strong tertiary and quaternary care. Comparable in terms of urban, single-specialty-adjacent service lines (mother & child, urology, IVF) and a relevant IPO/liquidity benchmark for AHH's public-market trajectory.
  • CARE Hospitals: Multi-specialty hospital chain in India with strong presence in urology, nephrology and dialysis — directly adjacent to AHH's AINU vertical. Comparable for hospital-network scaling, dialysis-program throughput, and transplant capabilities.

Direct peers

  • Cloudnine Hospitals: India's leading single-specialty women, maternity and child-care hospital chain with a comparable NICU- and gynaecology-led model. Direct competitor to Motherhood Hospitals across metros and Tier-1 cities and the closest pure-play comparable for that AHH vertical.
  • Rainbow Children's Hospital: Single-specialty paediatric, women and child hospital chain listed in India. Direct competitor to Motherhood in the same NICU-led, paediatric subspecialty category and a key public-market reference for AHH's women & child vertical.
  • Indira IVF: Among India's largest fertility/IVF chains by centre count, competing head-to-head with Nova IVF in tier-1 and tier-2 cities. Closest pure-play direct comparable on the fertility vertical that anchors AHH's growth thesis.
  • Oasis Fertility: Pan-India fertility chain with ART and embryology services that overlap directly with Nova IVF. Comparable on clinical protocol standardisation, embryologist scale, and tier-2/3 city expansion strategy.

Emerging players

  • Karkinos Healthcare: Technology-driven, distributed cancer-care platform in India where AHH's CTO previously served as CIO. Relevant because it operates a tech-enabled specialty model, intersects with AHH's former oncology vertical, and is a candidate counterparty for any future oncology re-entry or partnership.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Asia Healthcare Holdings(AHH) social profiles

Digital presence

Asia Healthcare Holdings(AHH) financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Asia Healthcare Holdings(AHH) leadership team

Management profile

Number of profiles

Profiles12 records

Asia Healthcare Holdings(AHH) subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Asia Healthcare Holdings(AHH) funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Asia Healthcare Holdings(AHH) M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Asia Healthcare Holdings(AHH)

What does Asia Healthcare Holdings(AHH) do?

Asia Healthcare Holdings (AHH) is a single-specialty healthcare operating and investment platform that acquires and scales hospital and clinic chains in India across three verticals: women and child care (Motherhood Hospitals), fertility and IVF (Nova IVF Fertility), and urology and nephrology (Asian Institute of Nephrology and Urology / AINU). The platform combines institutional capital (TPG Growth and GIC) with operating expertise to grow more than 150 hospitals and clinics across 80+ Indian cities, employing 6,100 staff and 2,000 doctors. AHH also runs in-house pathology work worth roughly 400 million rupees and is scoping gastroenterology as a future vertical.

Is Asia Healthcare Holdings(AHH) a public or private company?

Asia Healthcare Holdings(AHH) is a private company. It is classified as private equity controlled and is currently operating.

When was Asia Healthcare Holdings(AHH) founded?

Asia Healthcare Holdings(AHH) was founded in 2016. It employs 5,001 to 10,000 people.

Where is Asia Healthcare Holdings(AHH) based?

Asia Healthcare Holdings(AHH) is headquartered in Bengaluru, India, in the Asia region.

How does Asia Healthcare Holdings(AHH) make money?

Three revenue lines are on record. Hospital & clinical service revenue is the primary driver. The others are in-house pathology & diagnostic revenue and healthcare investment platform returns.

Who are Asia Healthcare Holdings(AHH)'s main competitors?

Broad incumbents on record are Manipal Hospitals, Fortis Healthcare, Apollo Hospitals, Max Healthcare and CARE Hospitals. Direct peers are Cloudnine Hospitals, Rainbow Children's Hospital, Indira IVF and Oasis Fertility. Karkinos Healthcare is listed as an emerging player.

Does Asia Healthcare Holdings(AHH) have an API?

No public API is recorded for Asia Healthcare Holdings(AHH).

What industry is Asia Healthcare Holdings(AHH) in?

Asia Healthcare Holdings(AHH)'s product category is Single-specialty healthcare services. Its primary akta.pro industry code is HLAFAEAH, Hospital-at-Home / Acute Care at Home Programs, with a secondary code of HLACADAG, Multi-Location & Enterprise Practice Operations. Its NAICS code is 622310 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BusinessLineIs the colour of money changing the healthcare landscapeA parliamentary panel report in India has raised concerns that foreign capital influx is driving the monopolistic acquisition of mid-sized hospitals, potentially leading to higher medical costs and reduced care quality. Industry leaders from Asia Healthcare Holdings and Manipal Health Enterprises defend private equity investments, arguing they do not compromise patient care or clinical outcomes. The debate highlights a broader discussion on healthcare financing, with recommendations for increased government health expenditure to 5% of GDP.Medical BuyerPrivate equity doesn’t just fund hospitals, it now judges them tooA parliamentary panel in India has raised concerns regarding the increasing influence of private equity and foreign capital in the healthcare sector, prompting hospital operators to restructure their partnerships for better governance. This scrutiny comes as private equity investments have surged to approximately ₹1.05 lakh crore since 2021, enabling major chains like HCG and Asia Healthcare Holdings to expand capacity and modernize facilities. Hospital groups are now balancing the need for rapid capital infusion against regulatory demands for pricing transparency and clinical independence.BusinessLineGIC-backed Asia Healthcare eyes IPO in 12-18 months, awaits market stabilityAsia Healthcare Holdings (AHH), backed by GIC and TPG, is considering an IPO within 12-18 months, contingent on market stability. The company is exploring growth opportunities in healthcare sectors such as gastroenterology and pathology diagnostics, with plans to expand in Tier-2 and Tier-3 cities.MarketScreenerGIC-backed Asia Healthcare eyes IPO within 12-18 months, cautious on market volatilityAsia Healthcare Holdings is considering an IPO within 12-18 months, but remains cautious about market volatility. The GIC-backed firm has invested over $300 million in healthcare businesses and plans to expand into gastroenterology and pathology diagnostics. It does not need additional capital and could deploy up to $150 million over two years.HrtodayAsia Healthcare Holdings appoints Venkatesh Tarakkad as Chief Financial Officer & Head – Business DevelopmentAsia Healthcare Holdings (AHH) has appointed Venkatesh Tarakkad as Chief Financial Officer and Head of Business Development, effective immediately. Tarakkad brings over 30 years of corporate finance experience, having previously served as CFO at UpGrad, and will oversee finance, legal, business development, and internal audit functions across the company. The current CFO Ritesh Pandey will transition to the newly created role of Chief Business Officer for New Initiatives, continuing to support AHH's strategic growth and expansion into new verticals.The Times of IndiaAHH names Venkatesh Tarakkad as CFO; Ritesh Pandey moves to chief business officer role - The Economic TimesAsia Healthcare Holdings (AHH) has appointed Venkatesh Tarakkad as its new Chief Financial Officer and Head of Business Development, effective immediately. Tarakkad brings over three decades of experience in corporate finance, governance, and mergers and acquisitions, having previously served as CFO at edtech company UpGrad. In his new role, he will oversee finance across all AHH group companies along with legal, business development, and internal audit functions.BusinessLineHealthcare 2025–26: Is private investment the pill for growth?This article presents a podcast interview with Vishal Bali, Executive Chairman of Asia Healthcare Holdings, discussing major trends reshaping India's healthcare sector in 2025, including how consolidation has shifted from a strategic option to an industry-wide necessity driven by market fragmentation and rising middle-class demand. The conversation explores the surge in mergers and acquisitions, expanding opportunities in tier 2 cities, private equity's role in fueling growth, and how corporate hospitals are addressing gaps in healthcare access and quality. The discussion, featuring data inputs from EY-Parthenon India, offers an industry outlook on India's healthcare landscape heading into 2026.Forbes IndiaHow Vishal Bali is pushing for single-specialty hospitalsVishal Bali, former CEO of Wockhardt and Fortis, has been focusing on establishing single-specialty hospitals across India through Asia Healthcare Holdings (AHH), which is backed by Singapore’s GIC. The single-specialty hospital market is valued at about $15 billion, with $5 billion in organized healthcare, and GIC recently invested $150 million to become the largest shareholder in AHH. This capital will help AHH expand into new healthcare areas such as gastrointestinal treatments, diagnostics, and pathology.CredenceresearchAsia Healthcare Holdings Invests ₹400 Crore to Expand AINU’s Uro Nephrology FootprintAsia Healthcare Holdings (AHH) announced a ₹400 crore investment over FY25–FY30 into the Asian Institute of Nephrology and Urology (AINU), one of India's largest single-specialty uro-nephro care chains, with AHH already holding a >70% stake and having deployed a total of ₹1,000 crore in AINU since FY24. The capital will fund 13 new hospital additions across Tier 2 cities including Patna, Bhubaneshwar, and Coimbatore, with a planned CAPEX of ₹150 crore for 3–4 hospitals in FY26–27, and expansion of robotic surgery programs. The investment is timed against India's single-specialty hospital market projected to grow from $16.1 billion to $40 billion by 2032 at a 12.1% CAGR, as PE-backed single-specialty chains gain traction over multi-specialty models due to higher ROCE and scalability.XEconomic Times on X: "Asia Healthcare Holdings to invest Rs 400 crore in Asian Institute of Nephrology and Urology to double hospital network https:Asia Healthcare Holdings announced it will invest Rs 400 crore in Asian Institute of Nephrology and Urology over the next 4-5 years. AINU plans to use the investment to open 13 hospitals in Tier cities, doubling its current hospital network. The expansion represents a significant growth play in the specialty healthcare sector focused on nephrology and urology.